CTLA4 and neoplasm: When IR (8 Gy × 3) was combined with the immune checkpoint inhibitor (ICI) anti-CTLA-4, complete and durable regression of both the irradiated and non-irradiated mouse cell line TSA-derived tumor was observed [15].